key: cord-0854309-qti78vw9
authors: Rodriguez, Robert M.; Montoy, Juan Carlos C.; Hoth, Karin F.; Talan, David A.; Harland, Karisa K.; Eyck, Patrick Ten; Mower, William; Krishnadasan, Anusha; Santibanez, Scott; Mohr, Nicholas; Monica Bahamon, M.P.H.; Carlson, Jestin N.; Chisolm-Straker, Makini; Driver, Brian; Faine, Brett; D, Pharm; Galbraith, James; Giordano, Philip A.; Haran, John P.; Higgins, Amanda; Hinson, Jeremiah; House, Stacey; Idris, Ahamed H.; Kean, Efrat; Krebs, Elizabeth; Kurz, Michael C.; Lee, Lilly; Liang, Stephen Y.; Lim, Stephen C.; Moran, Gregory; Nandi, Utsav; Pathmarajah, Kavitha; Paxton, James H.; Perez, Yesenia; Rothman, Richard; Schrading, Walter A.; Shuck, Jessica; Slev, Patricia; Smithline, Howard A.; Souffront, Kimberly; Steele, Mark; St. Romain, Michelle; Stubbs, Amy; Swanson, Morgan; Tiao, Josh; Torres, Jesus R.; Trent, Stacy; Uribe, Lisandra; Venkat, Arvind; Volturo, Gregory; Wallace, Kelli; Weber, Kurt D.
title: COVID-19-Related Stress Symptoms Among Emergency Department Personnel
date: 2021-02-05
journal: Ann Emerg Med
DOI: 10.1016/j.annemergmed.2021.01.028
sha: 372ba172e653bf11c9b63e3a09e8620a5e5a8b78
doc_id: 854309
cord_uid: qti78vw9

Importance During the coronavirus disease 2019 (COVID-19) pandemic, frontline emergency department (ED) healthcare personnel (HCP) may be particularly susceptible to anxiety, burnout, and post-traumatic stress disorder (PTSD). Objectives Among a comprehensive range of ED HCP, to assess symptoms of anxiety and burnout; specific COVID-19 work-related stressors; PTSD risk; and to determine perceptions of whether COVID-19 serologic testing of HCP would decrease self-reported anxiety. Design Prospective cohort study (enrollment from 5/13/20-7/8/20) using electronic surveys to capture participant self-reported symptoms before and after serologic testing for anti-SARS-CoV-2 IgG antibodies. Setting and Participants: Physicians, nurses, advanced practice providers (APPs), and non-clinical ED personnel at 20 geographically diverse United States EDs. Measurements We evaluated these domains: 1) effects of the COVID-19 pandemic on overall stress and anxiety; 2) COVID-19-related work stressors; 3) burnout; and 4) PTSD risk (measured using the Primary Care-PTSD Screen for DSM-5 [PC-PTSD-5], a five-item screening instrument in which a score of ≥3 signifies high risk for PTSD). We also assessed perceptions of whether results of COVID-19 antibody testing decreased participants’ self-reported anxiety. Results Of 1606 participants, 100% and 88% responded to the baseline and follow-up surveys, respectively. At baseline, approximately half (46.1%) reported symptoms of anxiety and burnout from their work, and 308 (19.2%, 95% CI 17.3-21.1%) respondents screened positive for elevated PTSD risk. Female respondents were more likely than males to screen positive (odds ratio [OR] 2.0, 95% CI 1.5-2.8). Common concerns included exposing their family and the health of co-workers diagnosed with COVID-19. After receiving antibody test results, 54% (95% CI 51.8-56.7) somewhat agreed, agreed, or strongly agreed that knowledge of their immune status had decreased their anxiety. A positive serology result indicating prior SARS-CoV-2 infection was associated with a higher likelihood of reporting decreased anxiety (2.83, 95% CI 1.28-6.25).

The coronavirus disease 2019 (COVID-19) pandemic has challenged healthcare personnel (HCP) throughout the healthcare system, leading to unprecedented levels of stress and anxiety. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Facing unique stressors during their frontline work, HCP in emergency departments (EDs) may be particularly vulnerable to poor mental health during the pandemic.

We previously reported moderate to severe stress levels induced by work during the pandemic and identified several potential stress mitigation measures, including broadly available SARS-CoV-2 testing of HCP, even for those not experiencing symptoms. 7 That study, however, was limited to academic emergency medicine physicians in California, New Jersey, and Louisiana. Little is known about the effects on other ED personnel in a geographically diverse sample of EDs across the United States.

The objectives of the current study, conducted during the acute phase of the COVID-19 pandemic, were: 1) to assess symptoms of anxiety and burnout, and risk for post-traumatic stress disorder (PTSD) in a national sample (20 geographically diverse U.S. hospitals) of ED personnel over a broad range of staff roles, including nurses and non-clinical personnel (e.g., clerks and others without routine patient contact); 2) to describe specific concerns of ED personnel arising from their work during the pandemic; and 3) to determine whether the previously-reported stress mitigation measure of SARS-CoV-2 serologic testing for ED personnel would decrease self-reported anxiety.

J o u r n a l P r e -p r o o f 3 We conducted this prospective cohort study as part of the COVID-19 Evaluation of Risks in Emergency Departments Project (COVERED), a SARS-CoV-2 infection surveillance analysis of physicians, nurses, advanced practice providers (nurse practitioners and physician assistants;APPs), and non-clinical ED personnel in 20 U.S. academic EDs in 15 states; the protocol has been previously described. 15 Participants in the parent study were recruited from ED staff who had not previously been diagnosed with COVID-19. The sample size was determined by the parent study, which included 1,606 participants (approximately 40 doctors or APPs, 20 nurses and 20 non-clinical ED personnel at each of the 20 sites). This project was reviewed by a CDC Human Subjects Advisor (STARS Tracking Number: 0900f3eb81b18773, NCEZID Tracking Number: 040920PK) and classified on 9 April 2020 as public health surveillance deemed not to be research under the provision as defined in 45 CFR 46.102(l) (2) . It was reviewed by the institutional review boards at all sites, and informed consent was obtained from all participants. We followed the Strengthening the Reporting of Observational Studies in Epidemiology guidelines. 16 

We administered baseline electronic surveys (as part of enrollment in the parent study) from 5/13/20-7/8/20 (during a one-week period at each site). Participants then underwent nasal swab reverse transcriptase polymerase chain reaction (RT-PCR; Architect i2000, Abbott Laboratories, Chicago, Illinois) and anti-SARS-CoV-2 IgG serologic testing (Cobas SARS-CoV-2, Roche, Basel, Switzerland). Approximately 2-3 weeks after receiving their test results, participants were asked to complete a follow-up survey.

After consulting with survey content experts, we utilized an abbreviated version of our previouslypublished mental health survey 7 to assess the following domains: 1) effects of the COVID-19 pandemic on stress and anxiety symptoms (hereafter collectively referred to as "COVID-19 stress and J o u r n a l P r e -p r o o f 4 anxiety"); 2) work-related stressors; 3) work-related symptoms of emotional exhaustion, cynicism, and burnout (hereafter collectively referred to as "burnout"); and 4) PTSD risk (measured using the Primary Care-PTSD Screen for DSM-5 [PC-PTSD-5], a validated five-item screening instrument in which a score of ≥3 signifies high risk for PTSD). 17 COVID-19 stress, work-related stressors, and job stress over the prior week were rated on a 7-point Likert scale where 1 = not at all, 4 = somewhat, and 7 = extremely. Scores ≥4 were considered elevated stress responses. To assess the perceived stress mitigation effect of serologic testing, we asked participants to rate their agreement with the following statements: "Knowing my prior exposure and immunity to COVID-19 by serologic (blood) testing would decrease my anxiety" (prior to testing), and "Knowing my prior exposure and immunity to COVID-19 by serologic (blood) testing has decreased my anxiety" (after receiving their test result).

Both questions were rated on a 7-point Likert scale where 1 = strongly disagree and 7 = strongly agree. See Supplement for survey questions.

We report HCP characteristics and key responses as raw counts, frequencies, percentages, medians, and interquartile ranges (IQRs). Logistic regression was used to measure the difference in the percentage of the participants who screened positive for PTSD symptoms; the model included site and participant random effects. We performed explanatory multivariable logistic regression to identify factors associated with risk for PTSD and antibody positive-associated decrease in anxiety, in which a positive response was defined as any level of agreement that testing decreased anxiety. We performed multivariable logistic regression to identify factors associated with a score of 4 or greater on questions about stress/anxiety due to COVID-19 and job-related emotional exhaustion/burnout.

Variables included in multivariable models were selected a priori based on existing literature and included the following participant characteristics: quartiles of age, gender, race/ethnicity, home living situation (living alone or with a spouse / significant other, children, roommates, or other family), type J o u r n a l P r e -p r o o f 5 of HCP (physician, APP, nurse, or non-clinical staff), and community COVID-19 prevalence at time of baseline survey (quartiles as determined by local public health reports). [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Baseline models also included a dichotomous variable for participant belief that they had previously been infected (but not diagnosed) with SARS-CoV-2, and follow-up models included SARS-CoV-2 RT-PCR test results and serology test results. Standard errors were clustered at the site level. All analyses were conducted using Stata v13.0 (StataCorp LLC, College Station, TX).

Of 1606 participants in the parent study, 1606 (100%) completed the baseline survey (638 physicians, 156 APP, 410 nurses, and 402 non-clinical staff) and 1413 (88%) completed the follow-up survey ( Table 1) .

Before serologic testing, 1030 (64%) respondents (64% of physicians/APPs, 68% of nurses and 61% of non-clinical staff) reported feeling stress and anxiety due to COVID-19 "somewhat" or more strongly. HCP characteristics associated with reporting higher stress and anxiety included female Table 2 ).

Participants expressed concerns about specific worries described in Figure 1 . The highest-rated (greatest) concerns were secondarily exposing participants' family members (median score 5 on the J o u r n a l P r e -p r o o f 

Prior to testing, 741 (46%) respondents (40% of physicians/APPs, 55% of nurses, and 50% of nonclinical staff) reported feeling burnout symptoms in the prior week "somewhat" or more strongly. 

Prior to testing, 308 (19%) respondents (18% of physicians/APPs, 23% of nurses, and 18% of nonclinical staff) screened positive for PTSD risk (score ≥3). Female respondents were more likely to screen positive than males (OR 2.03, 95%CI 1.49-2.78). Among participants who responded to both surveys, fewer respondents (12.5%) screened positive for PTSD risk after testing (difference 6.5%, 95%CI 4.6-8.5%; Figure 2 ).

Community COVID-19 prevalence was not associated with positive responses to the anxiety, burnout, or PTSD symptom questions in any of the multivariable logistic regression models ( Table 2) .

J o u r n a l P r e -p r o o f 7 Prior to COVID-19 testing, 75.6% (95% CI 73.5-77.7%) of participants somewhat agreed, agreed, or strongly agreed that knowing their prior exposure and immunity to SARS-CoV-2 would decrease their anxiety. After receiving their test results, 54% (95% CI 51.8-56.7) somewhat agreed, agreed, or strongly agreed that knowledge of their immune status had decreased their anxiety. A positive serology result, i.e. evidence of past infection, was associated with a higher likelihood of reporting a decrease in anxiety (OR 2.83, 95%CI 1.28-6.25; Table 2 ).

In this study conducted at 20 U.S. EDs, four central findings advance our understanding of the impact of the COVID-19 pandemic on the mental well-being of U.S. frontline ED personnel. First, we found that self-reported feelings of work-related anxiety, emotional exhaustion, and burnout are prevalent across the full spectrum of ED staff, including nurses and non-clinical personnel. Second, primary stressors include concerns about HCP and patients infecting others with COVID-19 and the health of coworkers diagnosed with COVID-19. Third, over half of ED personnel reported one or more mental health symptoms of PTSD (e.g., nightmares), and nearly one in five screened positive for elevated PTSD risk. Finally, most respondents (54%) reported that their anxiety was diminished by learning their test results, though this was a lower proportion of participants than those who predicted that serologic testing would decrease their anxiety (75%). This mitigating effect was especially pronounced among those who had positive serology for antibodies to COVID-19.

Our findings are consistent with those of international investigators, who have documented increased symptoms of anxiety, depression, insomnia, and PTSD risk in HCP and have found slightly greater risk in women. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] In our previous research, conducted from February 23 to April 10, 2020, the limited availability of personal protective equipment (PPE) was academic emergency physicians' primary J o u r n a l P r e -p r o o f concern. 7 At the later time of this study, PPE was no longer among the top five listed worries, suggesting that PPE became more widely available.

In terms of practical, actionable items from this research, the stress mitigation effect of serologic testing has substantial face validity. ED personnel serve as the initial hospital caregivers for the majority of critically ill patients with known or suspected COVID-19 infection. They also deal with many patients with undifferentiated symptoms consistent with COVID-19, whose SARS-CoV-2 test results are often unknown while in the ED. This can lead to uncertainty of ED personnel regarding exposure to COVID-19 and secondary risk to their families. By clarifying exposure and risks, testing of HCP may logically relieve anxiety, especially in those who test positive indicating some level of perceived immunity.

Our findings were remarkably consistent across all demographic groups and "hotspot" sites. The Centers for Disease Control and Prevention (CDC) advocates for the early recognition of the signs of stress (irritation, anxiety, lack of motivation, feeling burned out, and difficulty sleeping) in ED personnel. 18 Along with following CDC recommendations, guidance to employers to develop and implement a COVID-19 response plan (including healthy work conditions, improved leave policies, and resilience building among workers), 19 it is important that ED leadership consider provision of serologic testing for ED personnel. Considering that over half of participants reported experiencing at least one symptom of PTSD and as many as 20% were at elevated risk, employers should also similarly consider assuring that HCPs are aware of available well-being programs and encourage workers to take time off, get adequate rest, and utilize resources available to them.

Our study selected HCP from large academic centers and may not reflect the experience of HCPs in smaller community EDs. Because of the potentially taxing extent of survey items for the parent project, we used abbreviated scales instead of comprehensive instruments to measure anxiety, burnout, and risk for PTSD. Although our questions were reviewed by survey and content methodology experts and we used questions from some validated instruments, our final survey instrument and questions were not externally validated.

We only surveyed two points in time (approximately three weeks apart) during one stage of a lengthy pandemic and were unable to observe or control for day-to-day variables that could impact participants' reports of anxiety levels, burnout, and PTSD symptoms, such as a very stressful workday prior to completing the survey. Similarly in terms of timing, we conducted this work from May to July 2020 -prior to COVID-19 vaccination of ED providers. Receipt of COVID-19 vaccines has likely had a substantial impact on HCP emotional well-being and anxiety levels. Finally, lack of a control group who did not receive serologic testing precludes causal inferences regarding relief in anxiety and PTSD symptom reduction after serologic testing.

Symptoms of anxiety, emotional exhaustion, and burnout are prevalent across the full spectrum of ED staff during the COVID-19 pandemic, and as many as one-fifth are at risk for PTSD. Future work should focus on organizational efforts to prevent pandemic-associated stress to the extent possible through healthy work design and supportive workplace policies. As HCP continue to serve on the frontlines in this pandemic, it is critical to explore ways to mitigate the long-term effects of chronic stress. Increasing provision of SARS-CoV-2 testing shows promise for achieving this aim. 2 Home living categories not mutually exclusive, except for alone. 3 Community cumulative incidence defined as cumulative cases as of 6/29/20. 

Symptoms of burnout in intensive care unit specialists facing the COVID-19 outbreak

Psychological symptoms among frontline healthcare workers during COVID-19 outbreak in Wuhan

Mental health and psychosocial problems of medical health workers during the COVID-19 epidemic in China

Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019

Mental Health Outcomes Among Frontline and Second-Line Health Care Workers During the Coronavirus Disease 2019 (COVID-19) Pandemic in Italy

Depression, anxiety, stress levels of physicians and associated factors in COVID-19 pandemics

Academic Emergency Medicine Physicians' Anxiety Levels, Stressors, and Potential Stress Mitigation Measures During the Acceleration Phase of the COVID-19 Pandemic

Burnout and somatic symptoms among frontline healthcare professionals at the peak of the Italian COVID-19 pandemic

Posttraumatic stress symptoms of health care workers during the corona virus disease 2019

Psychological impact of 2019 novel coronavirus (2019-nCoV) outbreak in health workers in China

Psychological impact of healthcare workers in China during COVID-19 pneumonia epidemic: A multi-center cross-sectional survey investigation

Depression, anxiety, stress levels of physicians and associated factors in COVID-19 pandemics

A multinational, multicentre study on the psychological outcomes and associated physical symptoms amongst healthcare workers during COVID-19 outbreak

Psychological status of medical workforce during the COVID-19 pandemic: A cross-sectional study

COVID-19 Evaluation of Risk in Emergency Departments

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

The primary care PTSD screen for DSM-5 (PC-PTSD-5): development and evaluation within a Veteran primary care sample

COVID-19 Stress Among Your Workers? Healthy Work Design and Well-Being Solutions Are Critical

Personnel and First Responders: How to Cope with Stress and Build Resilience During the COVID-19 Pandemic

The authors would like to acknowledge the following participating Project COVERED emergency departments: Allegheny